Journey Medical Corporation - Income Statement (TTM)

Journey Medical Corporation
US ˙ NasdaqCM ˙ US48115J1097

Income Statement (TTM)

Journey Medical Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 45 45 49 59 63 76 79 75 74 63 61 80 79 80 78 58 56 56 56
Change (%) 0.09 10.34 20.67 6.39 19.92 3.97 -4.44 -2.06 -15.04 -1.79 29.97 -0.89 1.03 -2.90 -25.63 -2.83 0.19 0.27
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 15 15 18 23 26 30 31 30 31 29 29 28 23 22 20 19 21 20 19
Change (%) 3.02 18.74 26.82 13.00 16.79 3.51 -2.09 1.63 -5.70 1.50 -3.71 -19.29 -1.95 -9.09 -5.61 8.40 -5.80 -4.00
% of Revenue 32.77 33.73 36.30 38.15 40.52 39.46 39.29 40.26 41.77 46.37 47.92 35.50 28.91 28.06 26.27 33.34 37.19 34.97 33.48
Gross Operating Profit 30 30 31 37 38 46 48 45 43 34 32 52 56 58 57 39 35 37 38
Change (%) -1.34 6.06 17.16 2.32 22.06 4.26 -5.96 -4.55 -21.75 -4.63 60.96 9.24 2.25 -0.48 -32.76 -8.45 3.75 2.57
% of Revenue 67.23 66.27 63.70 61.85 59.48 60.54 60.71 59.74 58.23 53.63 52.08 64.50 71.09 71.94 73.73 66.66 62.81 65.03 66.52
SG&A 22 23 26 31 40 48 56 61 59 58 55 48 44 39 37 40 40 42 44
Change (%) 4.55 11.15 19.19 30.21 21.31 15.31 8.65 -1.77 -2.39 -5.25 -12.62 -8.63 -11.10 -4.64 7.41 0.55 5.35 3.67
% of Revenue 49.60 51.81 52.19 51.55 63.09 63.82 70.79 80.48 80.72 92.74 89.47 60.15 55.46 48.80 47.92 69.21 71.62 75.30 77.85
R&D 14 15 17 18 7 9 11 12 11 10 8 13 13 11 10 2 1
Change (%) 5.77 13.68 7.65 -62.63 30.30 26.09 7.01 -7.13 -5.36 -26.73 77.59 -6.43 -11.07 -11.55 -79.59 -45.38
% of Revenue 28.00 24.55 26.23 23.54 8.46 11.54 14.85 18.71 17.69 12.88 9.52 16.74 16.13 19.29 17.56 3.58 1.95
OpEx 37 38 57 68 82 96 93 99 101 99 95 87 78 79 76 76 70 63 63
Change (%) 3.94 50.26 18.34 20.91 17.14 -2.83 6.64 1.70 -2.38 -3.49 -9.04 -9.92 1.72 -4.91 0.30 -7.88 -9.54 0.16
% of Revenue 82.37 85.54 116.50 114.25 129.84 126.83 118.54 132.28 137.35 157.82 155.08 108.54 98.65 99.32 97.27 131.18 124.36 112.29 112.16
Operating Income 8 6 -8 -8 -19 -20 -15 -24 -28 -36 -34 -7 1 1 2 -18 -14 -7 -7
Change (%) -17.93 -225.92 4.25 122.76 7.82 -28.16 66.37 13.34 31.52 -6.44 -79.85 -115.69 -49.44 292.61 -948.16 -24.08 -49.47 -0.74
% of Revenue 17.63 14.46 -16.50 -14.25 -29.84 -26.83 -18.54 -32.28 -37.35 -57.82 -55.08 -8.54 1.35 0.68 2.73 -31.18 -24.36 -12.29 -12.16
Interest Expense -1 -1 -2 -3 -7 -7 -6 -6 -2 -2 -3 -2 -2 -2 -1 -2 -3 -3 -3
Change (%) 9.81 155.19 60.63 123.87 2.39 -12.33 -12.89 -63.29 12.93 13.25 -11.27 -25.88 -6.01 -12.09 34.93 42.63 12.70 12.29
% of Revenue -1.57 -1.72 -3.98 -5.29 -11.14 -9.51 -8.02 -7.31 -2.74 -3.64 -4.20 -2.87 -2.14 -2.00 -1.81 -3.28 -4.81 -5.41 -6.06
Net Income 5 4 -9 -20 -44 -46 -41 -41 -30 -38 -39 -12 -4 -4 1 -18 -15 -8 -9
Change (%) -20.97 -317.15 117.75 122.86 3.74 -9.50 -1.37 -27.27 29.56 2.18 -68.51 -68.81 7.94 -120.27 -2,275.09 -19.98 -43.41 5.24
% of Revenue 11.86 9.37 -18.44 -33.27 -69.68 -60.28 -52.47 -54.16 -40.22 -61.33 -63.81 -15.46 -4.87 -5.20 1.09 -31.74 -26.14 -14.76 -15.49

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista